Key result
Pacemaker or defibrillator implantation increased ischemia-modified albumin levels from 97.6 U/mL at baseline to 101.4 U/mL at 6 hours and 102.1 U/mL at 48 hours.
Why the study?
Does pacemaker or defibrillator implantation induce changes in ischemia-modified albumin (IMA) plasma levels in patients undergoing device implantation?
Observational (n=64)
Does pacemaker or defibrillator implantation induce changes in ischemia-modified albumin (IMA) plasma levels in patients undergoing device implantation?
Permanent pacemaker and defibrillator implantation is associated with a significant rise in ischemia-modified albumin, suggesting the procedure induces myocardial ischemia in addition to necrosis.
Answers are grounded in this paper and cite their sources.
Device implantation may induce ischemia; leaves open IMA's role in periprocedural monitoring for future studies.
BACKGROUND: Ischemia-modified albumin (IMA) is considered a marker of myocardial ischemia whereas cardiac enzymes are released when cardiac necrosis occurs. It has previously been shown that permanent pacemaker-defibrillator insertion is associated with myocardial injury expressed as cardiac enzyme rise. OBJECTIVE: We assessed whether pacemaker-defibrillator implantation also induces changes in IMA plasma levels and whether, therefore, myocardial ischemia precedes necrosis. METHODS: We studied 64 consecutive patients undergoing pacemaker or defibrillator implantation; 43 were men and 21 women and their age was 70 +/- 11 years (range 23-84 years). Blood samples were collected at baseline, six hours and 48 hours following the procedure. IMA measured by the albumin cobalt binding test (ACB, Integra 800 analyzer), as well as creatine kinase (CK), the MB isoenzyme of creatine kinase (CK-MB) and cardiac troponin I (Tn-I) were evaluated. RESULTS: Data analysis showed that compared to baseline measurements, IMA increased at six hours (P = 0.015) and at 48 hours (P = 0.003)[97.6 +/- 10.2 vs 101.4 +/- 10.7 vs 102.1 +/- 9.2 U/mL at baseline, six hours and 48 hours, respectively]; similarly, CK increased at six hours (P = 0.0001) and remained high at 48 hours (P = 0.0001) [74.9 +/- 49.9 vs 136.1+/-186.7 vs 115.2 +/- 63.9 mIU/mL], while CK-MB increased at six hours (P = 0.0001), but returned to baseline values at 48 hours (P = 0.05) [0.90 +/- 0.89 vs 1.27 +/- 134 vs 0.71 +/- 0.63 ng/mL] and Tn-I increased at six hours (P = 0.0001) and returned to baseline levels at 48 hours (P = 0.32) [0.057 +/- 0.23 vs 0.16 +/- 0.36 vs 0.03 +/- 0.045 ng/mL]. CONCLUSION: Permanent pacemaker-defibrillator insertion is associated with myocardial ischemia and necrosis.
No takes yet. Share an insight, caveat, or question.
Sbarouni et al. (2007) conducted an observational in Patients undergoing pacemaker or defibrillator implantation (n=64). Pacemaker or defibrillator implantation vs. Baseline was evaluated on Ischemia-modified albumin (IMA) plasma levels at 6 hours (p=0.015). Pacemaker or defibrillator implantation increased ischemia-modified albumin levels from 97.6 U/mL at baseline to 101.4 U/mL at 6 hours and 102.1 U/mL at 48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: